InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: sts66 post# 3422

Tuesday, 03/26/2013 8:17:54 AM

Tuesday, March 26, 2013 8:17:54 AM

Post# of 425868
Momentum in payers is picking up for Vascepa.

http://www.ft.com/cms/s/2/e9c78948-958f-11e2-a4fa-00144feabdc0.html#axzz2ObhnLONz

"Garfield noted there has been positive momentum from payers since AstraZeneca announced last March that Brilinta received Plan Preferred Tier 2 formulary access on Medco Health Solutions’ National commercial formulary and preferred brand formulary status on its Medicare Part D drug list."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News